Bioactive nanotherapeutic trends to combat triple negative breast cancer

Bioactive nanotherapeutic trends to combat triple negative breast cancer

The management of aggressive breast cancer, particularly, triple negative breast cancer (TNBC) remains a formidable challenge, despite treatment advancement. Although newer therapies such as atezolizumab, olaparib, and sacituzumab can tackle the breast cancer prognosis and/or progression, but achiev...

Full description

Bibliographic Details
Main Authors: Pallabita Chowdhury, Upasana Ghosh, Kamalika Samanta, Meena Jaggi, Subhash C. Chauhan, Murali M. Yallapu
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2021-10-01
Series:Bioactive Materials
Subjects:
Breast cancer treatment
Triple negative breast cancer
Chemotherapy
Nanoparticles
Membrane cloaked nanoparticles
Nanomedicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2452199X21000992

Internet

http://www.sciencedirect.com/science/article/pii/S2452199X21000992

Similar Items